[{"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0182-2015", "product_description": "CHORIONIC GONADOTROPIN, 5000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "117 vials", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #:  20140909@5, discard date: 3/8/2015;  Lot #:  20140728@57, discard date: 1/14/2015."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0166-2015", "product_description": "Tri-mix T25, 4.413 mg/0.145 mg/1.475 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08122014@23, Exp 11/10/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0089-2015", "product_description": "Hydromorphone/bupivacaine (PF) 0.5 mg/0.2 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08152014@34, Exp 9/14/2014", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022088"], "brand_name": ["TORISEL"], "generic_name": ["TEMSIROLIMUS"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "product_ndc": ["0008-1179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["722289", "725108"], "spl_id": ["bf2e0d62-5f93-4a04-852b-829296b5bdd2"], "spl_set_id": ["95b7dc92-2180-42f1-8699-3c28f609e674"], "package_ndc": ["0008-1179-01", "0008-1279-01", "0008-1125-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "69479", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0235-2015", "product_description": "TORISEL Kit (temsirolimus) injection, 25 mg/mL, 1 vial of TORISEL 25 mg/mL and 1 vial of 2.2 mL DILUENT per carton, Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101; Diluent \u0013 MADE IN ITALY; NDC 0008-1179-01.", "product_quantity": "16,000 kits", "reason_for_recall": "Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.", "recall_initiation_date": "20141010", "center_classification_date": "20141104", "termination_date": "20170414", "report_date": "20141112", "code_info": "Kit Lot #: AIEM/13, Exp 05/16 that contain diluent lots AHZW/11 and AHZW/12"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA074137"], "brand_name": ["BUPRENORPHINE HYDROCHLORIDE"], "generic_name": ["BUPRENORPHINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-2012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE"], "rxcui": ["1655032"], "spl_id": ["d17fb147-6a4a-4e37-9b72-71c5c5c4ff01"], "spl_set_id": ["23aa1bb3-cecf-4e62-29bb-48488bb66fc3"], "package_ndc": ["0409-2012-03", "0409-2012-32"], "is_original_packager": [true], "unii": ["56W8MW3EN1"]}, "product_type": "Drugs", "event_id": "69163", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide", "recall_number": "D-1604-2014", "product_description": "Buprenorphine Hydrochloride Injection, CIII, 0.3 mg base/mL ,1 mL, 10  Carpuject Sterile Cartridge Units with Luer Lock, Slim-Paks, F Intramuscular or Intravenous Use, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2012-32", "product_quantity": "373,180 Carpuject units", "reason_for_recall": "Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.", "recall_initiation_date": "20140909", "center_classification_date": "20140919", "termination_date": "20170317", "report_date": "20141001", "code_info": "Lot Number:  35-730-LL, 35-745-LL, Exp:  1 FEB 2015"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0134-2015", "product_description": "Sodium tetradecyl sulfate 2% (PF) injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "6.3 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08112014@50, Exp 9/10/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0187-2015", "product_description": "DMPS-preservative free, 50 mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "280 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140724@24/5, discard date: 10/22/2014;  Lot #: 20140724@25, discard date: 10/22/2014;  Lot #: 20140826@12, discard date: 11/24/2014."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0143-2015", "product_description": "Triamcinolone acetonide (PF) 40 mg/mL injection suspension packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "100 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06192014@16, Exp 9/15/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Overland Park", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69674", "recalling_firm": "Perry Drug Inc.", "address_1": "12200 W 106th St Ste 140", "address_2": "N/A", "postal_code": "66215-2305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and Missouri", "recall_number": "D-0271-2015", "product_description": "Cyclosporine 0.045 % Sol PF, 12 mL bottle, Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-5120-67", "product_quantity": "3 vials", "reason_for_recall": "Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141107", "center_classification_date": "20141124", "termination_date": "20151103", "report_date": "20141203", "code_info": "141013CC, 11/13/14", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68218", "recalling_firm": "Eugene Oregon, Inc.", "address_1": "54 Spinythorn  Road", "address_2": "N/A", "postal_code": "19056", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC", "recall_number": "D-1614-2014", "product_description": "MOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Springville, UT 84663", "product_quantity": "57 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.", "recall_initiation_date": "20140505", "center_classification_date": "20140929", "termination_date": "20150401", "report_date": "20141008", "code_info": "All lots"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0064-2015", "product_description": "Bupivacaine hydrochloride 0.25% injectable packaged in an amber glass injectable vial,Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "15 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08112014@31, Exp 9/10/2014", "more_code_info": ""}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Superpotent Drug: Qualitest Pharmaceuticals is initiating a recall of three flavors of Acetaminophen Oral Suspension Liquid 160mg/5mL for failure of the product assay at the 12 month timepoint.", "address_2": "", "product_quantity": "101208 units", "code_info": "Codes:  L084A13A, L095F13A, L027H13A, L102K13A", "center_classification_date": "20141021", "distribution_pattern": "Nationwide", "state": "AL", "product_description": "CHILDREN'S Q-PAP, Acetaminophen, ORAL SUSPENSION, CHERRY FLAVOR, Active ingredient (in each 5 mL = 1 tsp) Acetaminophen USP 160 mg, 4 FL OZ (118 mL), Made in the USA for Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-0842-54, OTC", "report_date": "20141029", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualitest Pharmaceuticals", "recall_number": "D-0038-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69014", "termination_date": "20160202", "more_code_info": "", "recall_initiation_date": "20140806", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0164-2015", "product_description": "Tri-mix T106, 30 mg/1 mg/25 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "420 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06232014@48, Exp 9/21/2014; 06262014@9, Exp 9/24/2014; 08192014@29, Exp 11/17/2014", "more_code_info": ""}, {"country": "United States", "city": "Levittown", "address_1": "2091 Hartel Ave", "reason_for_recall": "Superpotent Drug: Bio-Pharm, Inc. is initiating a recall of one lot of Acetaminophen Oral Suspension Liquid 160mg/5mL failure of the product assay at the 6 month timepoint.", "address_2": "", "product_quantity": "35,739 bottles", "code_info": "Lot  3L20,  Exp. 11/15", "center_classification_date": "20141017", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Rugby Children's Pain and Fever Acetaminophen Oral Suspension 160 mg/5 mL, Cherry Flavor, 2 FL. oz bottle, OTC,   Distributed by: Rugby Laboratories Livonia, MI 48150,  NDC 0536-3606-96    Major Children's Mapap Suspension Liquid, Cherry Flavor,  4 FL OZ bottle, OTC,  Distributed by: Major Pharmaceuticals Livonia, MI 48150 , NDC 0904-6308-20,", "report_date": "20141029", "classification": "Class II", "openfda": {}, "recalling_firm": "Bio-pharm, Inc.", "recall_number": "D-0028-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "68847", "termination_date": "20150810", "more_code_info": "", "recall_initiation_date": "20140716", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68218", "recalling_firm": "Eugene Oregon, Inc.", "address_1": "54 Spinythorn  Road", "address_2": "N/A", "postal_code": "19056", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC", "recall_number": "D-1613-2014", "product_description": "Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.", "product_quantity": "136 boxes", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.", "recall_initiation_date": "20140505", "center_classification_date": "20140929", "termination_date": "20150401", "report_date": "20141008", "code_info": "All lots"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0124-2015", "product_description": "Prednisolone acetate 50 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "55 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 05082014@23, Exp 11/4/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019115"], "brand_name": ["FENTANYL CITRATE"], "generic_name": ["FENTANYL CITRATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-9094", "0409-9093"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FENTANYL CITRATE"], "rxcui": ["1735003", "1735004", "1735006", "1735007", "1735008", "1735013"], "spl_id": ["e4b31fdd-00af-416d-b14e-dbac0c83da97"], "spl_set_id": ["bfa8018a-4cbc-434b-e09e-782872b0340a"], "package_ndc": ["0409-9093-37", "0409-9093-32", "0409-9093-45", "0409-9093-35", "0409-9093-41", "0409-9093-36", "0409-9093-31", "0409-9093-38", "0409-9094-12", "0409-9094-22", "0409-9094-18", "0409-9094-25", "0409-9094-17", "0409-9094-28", "0409-9094-16", "0409-9094-31", "0409-9094-41", "0409-9094-61"], "is_original_packager": [true], "unii": ["MUN5LYG46H"]}, "product_type": "Drugs", "event_id": "69971", "recalling_firm": "Hospira Inc.", "address_1": "375 N Field Dr", "address_2": "N/A", "postal_code": "60045-2513", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0294-2015", "product_description": "Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only,  25 units per box/50 units per case, Hospira Inc., Lake Forest, IL --- NDC 0409-9094-61", "product_quantity": "62,650 vials", "reason_for_recall": "Lack of Assurance of Sterility; improperly crimped fliptop vials", "recall_initiation_date": "20141203", "center_classification_date": "20141210", "termination_date": "20151002", "report_date": "20141217", "code_info": "Lot 41-099-DK, exp 01MAY2016, NDC 0409-9094-61"}, {"country": "United States", "city": "Randolph", "address_1": "540 Route Ten West", "reason_for_recall": "Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.", "address_2": "", "product_quantity": "52 vials", "code_info": "Lot #: 05202014@7, Exp 11/19/2014", "center_classification_date": "20141219", "distribution_pattern": "Directly to patients and physicians in FL, NJ, NY, and Puerto Rico", "state": "NJ", "product_description": "Magnesium Chloride 20% (200mg/mL) Sterile Injection, 50mL Multi-Dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.", "report_date": "20141231", "classification": "Class I", "openfda": {}, "recalling_firm": "Pharmacy Creations", "recall_number": "D-0307-2015", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "69184", "termination_date": "20150706", "more_code_info": "", "recall_initiation_date": "20140905", "postal_code": "07869", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0209-2015", "product_description": "PAPAV HCL/PHENTOL/PROSTAGL, 12mg/1mg/10mcg, injectable, 1.25 mL glass vial or 1.7 ml glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "25 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140827@30, discard date: 10/11/2014;  Lot #: 20140910@28/1.7, discard date: 10/25/2014;  Lot #: 20140917@2/1.25, discard date: 11/1/2014."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69572", "recalling_firm": "Prometheus Laboratories Inc.", "address_1": "9410 Carroll Park Dr", "address_2": "N/A", "postal_code": "92121-5201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0249-2015", "product_description": "Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b)  250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for Prometheus Laboratories, Inc., 9410 Carroll Park Drive, San Diego, CA 92121", "product_quantity": "16,296 bottles (60-count),  5,166 bottles (250-count)", "reason_for_recall": "Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.", "recall_initiation_date": "20141022", "center_classification_date": "20141114", "termination_date": "20160218", "report_date": "20141126", "code_info": "Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b)  250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for Prometheus Laboratories, Inc., 9410 Carroll Park Drive, San Diego, CA 92121    Lot #:  a) 140B11, Exp Feb 2016; 14B012, Exp Feb 2016;   14B013, Exp Feb 2016    Lot #: b) 13F046, Exp Jun 2015; 13K073, Exp Oct 2015; 13L075, Exp Oct 2015; 14B010, Exp Feb 2016."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69494", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and U.S. Virgin Islands.", "recall_number": "D-0278-2015", "product_description": "Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7902-09.", "product_quantity": "836,460 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.", "recall_initiation_date": "20141014", "center_classification_date": "20141125", "termination_date": "20151228", "report_date": "20141203", "code_info": "Lot # 34-017-JT; Exp. 10/15  Lot # 35-100-JT; Exp. 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA018998"], "brand_name": ["VASOTEC"], "generic_name": ["ENALAPRIL MALEATE"], "manufacturer_name": ["Bausch Health US LLC"], "product_ndc": ["0187-0140", "0187-0141", "0187-0142", "0187-0143"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENALAPRIL MALEATE"], "rxcui": ["858804", "858806", "858810", "858812", "858813", "858815", "858817", "858819"], "spl_id": ["18a458cc-976a-4019-bd85-18f55a224f45"], "spl_set_id": ["39631f1f-5d19-43c1-b504-bf56d991ed97"], "package_ndc": ["0187-0140-30", "0187-0140-90", "0187-0141-30", "0187-0141-90", "0187-0141-10", "0187-0142-30", "0187-0142-90", "0187-0142-10", "0187-0143-30", "0187-0143-90", "0187-0143-10"], "is_original_packager": [true], "unii": ["9O25354EPJ"]}, "product_type": "Drugs", "event_id": "68572", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0019-2015", "product_description": "Vasotec (enalapril maleate) tablets, RX only, Manufactured by Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada    2.5 mg  90 ct -  NDC 0187-0140-90    5 mg 30 ct - NDC  0187-0141-30    5 mg 90 ct - NDC 0187-0141-90    10 mg 30 ct - NDC 0187-0142-30    10 mg 90 ct - NDC 0187-0142-90    10 mg  1000 ct - NDC 0187-0142-10      20 mg 30 ct - NDC 0187-0143-30    20 mg 90 ct - NDC 0187-0143-90     20 mg 1000 ct - NDC 0187-0143-10          NDC #'s 64455-140, 64455-141, 64455-142 and 64455-143, 30 ct. bottles, 90 ct. bottles and 1000 ct. bottles", "product_quantity": "205,853 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.", "recall_initiation_date": "20140521", "center_classification_date": "20141010", "termination_date": "20150804", "report_date": "20141022", "code_info": "VASOTEC 2.5MG TAB 30CT  12K015P  exp.  9/30/2014      VASOTEC 2.5MG TAB 30CT  13G048P   exp.  07/31/2015    VASOTEC 2.5MG TAB 30CT  14A065P   exp. 07/31/2015    VASOTEC 2.5MG TAB 90CT  13G020P   exp. 07/31/2015      VASOTEC 2.5MG TAB 90CT   12K020P  exp.  9/30/2014      VASOTEC 2.5MG TAB 90CT  13B016P   exp. 9/30/2014      VASOTEC 5MG TAB 30CT   13B022P   exp. 2/28/2015    VASOTEC 5MG TAB 30CT 13B023P   exp. 2/28/2015    VASOTEC 5MG TAB 30CT  13C015P   exp. 02/28/2015    VASOTEC 5MG TAB 30CT  13E002P   exp. 02/28/2015    VASOTEC 5MG TAB 30CT 14A002P   exp.    11/30/2015    VASOTEC 5MG TAB 30CT  13L066P   exp. 11/30/2015    VASOTEC 5MG TAB 90CT   13B018P   exp. 2/28/2015      VASOTEC 5MG TAB 90CT  13G015P   exp. 06/30/2015      VASOTEC 10MG TAB 90CT   12M017P   exp. 11/30/2014    VASOTEC 10MG TAB 1000CT   12L105P   exp. 11/30/2014      VASOTEC 10MG TAB 30CT   12M016P   exp. 11/30/2014      VASOTEC 10MG TAB 30CT  13G013P   exp. 06/30/2015    VASOTEC 10MG TAB 30CT  13J081P  exp. 9/30/2015    VASOTEC 10MG TAB 90CT 12M025P   exp. 11/30/2014    VASOTEC 10MG TAB 90CT  13J082P   exp. 0/2015    VASOTEC 10MG TAB 90CT  13J085P   exp. 0/2015    VASOTEC 10MG TAB 90CT  13J094P   exp. 09/30/2015    VASOTEC 10MG TAB 1000CT  13J098P   exp. 09/30/2015    VASOTEC 10MG TAB 1000CT  13G011P   exp. 06/30/2015    VASOTEC 10MG TAB 1000CT  13J097P   exp. 09/30/2015    VASOTEC 20MG TAB 30CT   12J017P   exp. 5/31/2014    VASOTEC 20MG TAB 30CT   13C016P   exp. 2/28/2015    VASOTEC 20MG TAB 30CT  13E003P   exp. 02/28/2015    VASOTEC 20MG TAB 30CT  13L068P   exp. 09/30/2015    VASOTEC 20MG TAB 90CT  13J086P   exp. 09/30/2015    VASOTEC 20MG TAB 90CT  13J087P   exp. 09/30/2015      VASOTEC 20MG TAB 90CT   12M029P   exp. 11/30/2014    VASOTEC 20MG TAB 90CT   12M030P   exp. 11/30/2014    VASOTEC 20MG TAB 1000CT   12J023P   exp. 5/31/2014    VASOTEC 20MG TAB 1000CT  12L108P   exp. 11/30/2014    VASOTEC 20MG TAB 1000CT  13C088P   exp. 02/28/2015    VASOTEC 20MG TAB 1000CT  13J099P   exp. 09/30/2015    VASOTEC 20MG TAB 1000CT  13M054P   exp. 09/30/2015    VASOTEC 20MG TAB 1000CT  13M055P   exp. 12/31/2015    VASOTEC 20MG TAB 1000CT  14B054P   exp. 12/31/2015"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0212-2015", "product_description": "PAPAVERINE HCL/PHENTOLAMINE MES/ALPROSTADIL, 22mg/0.8mg/8mcg, injectable, 1.25 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "10 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140901@3, discard date: 10/19/2014"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0179-2015", "product_description": "CALCIUM CHLORIDE (COMPOUND), 100 mg/mL, Injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "580 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140815@47, discard date: 1/28/2015"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0062-2015", "product_description": "Bacteriostatic water for injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "600 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 03082014@2, Exp 9/4/2014; 04142014@8, Exp 10/11/2014; 05242014@2, Exp 11/20/2014; 06202014@20, Exp 12/17/2014; 08192014@33, Exp 2/15/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0192-2015", "product_description": "GENTAMICIN SULFATE, 100mg/1000mL, solution for irrigation, 400 mL plastic bottle,  RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "800 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140917@27, discard date: 10/22/2014"}, {"status": "Terminated", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68839", "recalling_firm": "Fougera Pharmaceuticals  Inc.", "address_1": "60 Baylis Rd", "address_2": "", "postal_code": "11747-3838", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0245-2015", "product_description": "FLUOCINONIDE GEL USP, 0.05%, Rx only, For External Use Only, Not For Ophthalmic Use, a) NET WT 15 gram tubes and b) NET WT 60 grams tubes, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0135-15 (15 g) and NDC 0168-0135-60 (60 g)", "product_quantity": "a) 59,622 Tubes; b)  43,178 Tubes", "reason_for_recall": "Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.", "recall_initiation_date": "20140828", "center_classification_date": "20141112", "termination_date": "20160621", "report_date": "20141119", "code_info": "a) 15 gram lot numbers: 549N, 550N,551N Exp. 1/2015, EB1961, Exp. 2/2017; b) 60 gram lot numbers: 546N, 547N, 548N, Exp. 1/2015, EB0144, Exp. 2/2017", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020931"], "brand_name": ["TIKOSYN"], "generic_name": ["DOFETILIDE"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-5800", "0069-5810", "0069-5820"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOFETILIDE"], "rxcui": ["284404", "284405", "285016", "310003", "310004", "310005"], "spl_id": ["44ca2ecb-252d-4880-8a4f-6e47f5bdd734"], "spl_set_id": ["02438044-d6a3-49e9-a1ac-3aad21ef2c8c"], "package_ndc": ["0069-5800-61", "0069-5800-60", "0069-5800-43", "0069-5810-61", "0069-5810-60", "0069-5810-43", "0069-5820-61", "0069-5820-60", "0069-5820-43"], "is_original_packager": [true], "upc": ["0300695810602", "0300695800603", "0300695820601"], "nui": ["N0000175426"], "pharm_class_epc": ["Antiarrhythmic [EPC]"], "unii": ["R4Z9X1N2ND"]}, "product_type": "Drugs", "event_id": "69724", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Pfizer shipped the affected product to 4,447 direct accounts.     No federal government accounts received the affected product directly from Pfizer Inc.", "recall_number": "D-0292-2015", "product_description": "Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.", "product_quantity": "31,569 HDPE Bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.", "recall_initiation_date": "20141203", "center_classification_date": "20141209", "termination_date": "20160927", "report_date": "20141217", "code_info": "Lot # a) H79652, Exp. 10/15; b) H79653, Exp. 10/15"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201089"], "brand_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "generic_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0397", "0591-0398"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICLOFENAC SODIUM", "MISOPROSTOL"], "rxcui": ["857706", "1359105"], "spl_id": ["03f24a4c-0fe7-446a-b64d-a7c6b12cae0f"], "spl_set_id": ["df8b8660-0c24-4848-8bea-c1b935090c66"], "package_ndc": ["0591-0397-19", "0591-0397-60", "0591-0398-60"], "is_original_packager": [true], "nui": ["N0000175785", "M0017811"], "pharm_class_epc": ["Prostaglandin E1 Analog [EPC]"], "pharm_class_cs": ["Prostaglandins E, Synthetic [CS]"], "unii": ["0E43V0BB57", "QTG126297Q"], "upc": ["305910397609"]}, "product_type": "Drugs", "event_id": "69237", "recalling_firm": "Actavis Laboratories, FL, Inc.", "address_1": "4955 Orange Dr", "address_2": "N/A", "postal_code": "33314-3902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1617-2014", "product_description": "Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0397-60, UPC 3 05910 39760 9.", "product_quantity": "6,041 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.", "recall_initiation_date": "20140424", "center_classification_date": "20140930", "termination_date": "20161223", "report_date": "20141008", "code_info": "Lot #: 660513A, Exp. 10/31/2014"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0177-2015", "product_description": "AVASTIN, 1.25mg/0.5mL, injectable, 0.05 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070.", "product_quantity": "5483/0.5 mL syringes", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140715@13, discard date: 11/3/2014;  Lot #: 20140716@25, discard date: 10/14/2014;  Lot #: 20140717@7, discard date: 10/15/2014;  Lot #: 20140724@14, discard date: 10/22/2014;  Lot #: 20140724@15, discard date: 10/22/2014;  Lot #: 20140729@11, discard date: 10/27/2014;  Lot #: 20140801@17, discard date: 10/30/2014;  Lot #: 20140805@1, discard date: 11/3/2014;  Lot #: 20140807@13, discard date: 11/5/2014;  Lot #: 20140811@30, discard date: 11/9/2014;  Lot #: 20140813@10, discard date: 11/11/2014;  Lot #: 20140825@8, discard date: 11/23/2014;  Lot #: 20140904@46, discard date: 12/3/2014;  Lot #: 20140909@12, discard date: 12/8/2014;  Lot #: 20140909@21, discard date: 12/8/2014;  Lot #: 20140912@30, discard date: 12/11/2014;  Lot #: 20140917@11, discard date: 12/16/2014;  Lot #: 20140917@9, discard date: 12/16/2014;  Lot #: 20140922@30, discard date: 12/21/2014;  Lot #: 20140814@15, discard date: 11/12/2014."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202033"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-4595", "0378-4596", "0378-4597", "0378-4598"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["f56f2132-0bd9-4818-a693-11b39f022bd4"], "spl_set_id": ["c50e8e36-42df-406b-8e63-eb8bf3f07e89"], "package_ndc": ["0378-4595-77", "0378-4595-10", "0378-4596-77", "0378-4596-10", "0378-4597-77", "0378-4597-10", "0378-4598-77", "0378-4598-05"], "is_original_packager": [true], "upc": ["0303784597774", "0303784598771", "0303784596777", "0303784595770"], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "68783", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0009-2015", "product_description": "Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles,  Rx only, Mfg by Mylan Pharmaceuticals, Inc. Morgantown, WV  26505. NDC 0378-4596-77.", "product_quantity": "15,966 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol", "recall_initiation_date": "20140703", "center_classification_date": "20141008", "termination_date": "20160920", "report_date": "20141015", "code_info": "Lot 3023805 Exp. 11/15", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0147-2015", "product_description": "Tri-mix, 15 mg/0.5 mg/10 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "5 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08132014@35, Exp 11/11/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Monroe Township", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M001"], "brand_name": ["E-Z-GAS"], "generic_name": ["ANTACID/ANTIFLATULENT"], "manufacturer_name": ["E-Z-EM, INC."], "product_ndc": ["10361-793"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ANHYDROUS CITRIC ACID", "DIMETHICONE", "SILICON DIOXIDE", "SODIUM BICARBONATE"], "spl_id": ["f48b7c5c-d874-4779-85de-ac364816af39"], "spl_set_id": ["4e12e1cb-b033-076d-e054-00144ff8d46c"], "package_ndc": ["10361-793-01"], "is_original_packager": [true], "nui": ["N0000175833", "N0000175835", "N0000175980", "N0000008556", "N0000175089", "N0000010282"], "pharm_class_moa": ["Acidifying Activity [MoA]", "Calcium Chelating Activity [MoA]"], "pharm_class_epc": ["Calculi Dissolution Agent [EPC]", "Anti-coagulant [EPC]"], "pharm_class_pe": ["Decreased Coagulation Factor Activity [PE]", "Skin Barrier Activity [PE]"], "unii": ["XF417D3PSL", "92RU3N3Y1O", "ETJ7Z6XBU4", "8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "69389", "recalling_firm": "Bracco Diagnostic Inc", "address_1": "259 Prospect Plains Road", "address_2": "Building H", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0014-2015", "product_description": "E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx Only, Manufactured  in USA for E-Z EM, Inc. Lake Success, NY 11042 by Tower Laboratories LTD Centerbrook, CT 06409   NDC 10361-793-01", "product_quantity": "58,050 packets", "reason_for_recall": "Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.", "recall_initiation_date": "20140918", "center_classification_date": "20141009", "termination_date": "20150630", "report_date": "20141015", "code_info": "Lot # F12C01; Exp. 02/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lexington", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68969", "recalling_firm": "Cubist Pharmaceuticals, Inc.", "address_1": "65 Hayden Ave", "address_2": "N/A", "postal_code": "02421-7994", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide   Foreign:  Israel, Taiwan", "recall_number": "D-0001-2015", "product_description": "CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.", "product_quantity": "4,966,575 Vials", "reason_for_recall": "Presence of Particulate Matter: Potential presence of glass particulate matter in the vials.", "recall_initiation_date": "20140801", "center_classification_date": "20141001", "termination_date": "20160629", "report_date": "20141008", "code_info": "Lot #: 081753F, 081803F, 081853F, Exp 08/2014; 090103F, 090153F, 090303F, 090353F, 090403F, 090453F, 090503F, Exp 09/2014; 100503F, 100553F, 100603F, 100653F, 100703F, 100753F, 100803F, 100853F, 100903F, Exp 10/2014; 101303F, 110303F, 110353F, 110403F, 110453F,   110503F, 110603F, 110653F, 110703F, Exp 11/2014; 120303F, 120353F, 120403F, 120453F, 120503F, 120553F, 120653F, 120703F, Exp 12/2014; 140453F, Exp 02/2015; 140603F, 140653F, 140703F, 150203F, 150253F, 150303F, 150353F, 150403F, 150453F, Exp 03/2015; 160853F, 160903F,   160953F, 161003F, 161053F, 161103F, Exp 05/2015; 181003F, 181053F, 181103F, 181153F, 181603F, 181653F, 181703F, Exp 06/2015; 201503F, 201553F, 201603F, Exp 08/2015; 201753F, 210453F, Exp 09/2015; 210503F, 210553F, 210603F, 210653F, 220353F, 220403F, 220453F, Exp 10/2015; 220503F, 220553F, 220603F, 230303F, 230353F, 230403F, 230453F, 230503F, 230553F, Exp 11/2015; 240053F, 240153F, 240203F, 240253F, 240303F, Exp 12/2015; 260603F, 260653F, 260703F, Exp 02/2016; 271303F, 271353F, 271403F, 271453F, 271503F, 271553F, Exp 03/2016; 280203F, 280253F, 280303F, 280403F, Exp 04/2016; 290203F, 290303F, 290353F, Exp 06/2016."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0171-2015", "product_description": "Fentanyl/bupivacaine 3000 mcg/30 mg/mL injectable packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08202014@31, Exp 9/19/2014", "more_code_info": ""}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.", "address_2": "", "product_quantity": "3,306 vials", "code_info": "Lot #: B032223AA; Exp: July 2016", "center_classification_date": "20141222", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "Dacarbazine, Injection, USP, 200mg,  vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.", "report_date": "20141231", "classification": "Class III", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-0313-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69900", "termination_date": "20161215", "more_code_info": "", "recall_initiation_date": "20141125", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0106-2015", "product_description": "Nalbuphine 10 mg/mL injection solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "30 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08182014@47, Exp 9/15/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040597"], "brand_name": ["BENZONATATE"], "generic_name": ["BENZONATATE"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "product_ndc": ["68382-091", "68382-247"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BENZONATATE"], "rxcui": ["197397", "283417"], "spl_id": ["52dc3ff3-f01b-4820-ba1e-b043a5b2c49a"], "spl_set_id": ["331c70dc-005e-4d96-a35c-4d2d810aa3b1"], "package_ndc": ["68382-247-01", "68382-247-05", "68382-091-01"], "is_original_packager": [true], "nui": ["N0000009010", "N0000175796"], "pharm_class_pe": ["Decreased Tracheobronchial Stretch Receptor Activity [PE]"], "pharm_class_epc": ["Non-narcotic Antitussive [EPC]"], "unii": ["5P4DHS6ENR"]}, "product_type": "Drugs", "event_id": "70101", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0325-2015", "product_description": "Benzonatate Capsules, USP, 100 mg,  Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534;  100-bottle capsules  - NDC 68382-247-01  500-bottle capsules - NDC 68382-247-05", "product_quantity": "19,536 units", "reason_for_recall": "Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.", "recall_initiation_date": "20141223", "center_classification_date": "20141223", "termination_date": "20170922", "report_date": "20141231", "code_info": "Lot #: MP2625, MP2626, MP2627 Exp 2/16; MP4875, MP4876, MP4877, MP4878  Exp 4/16; MP6482, MP6483, MP6484, MP6493, MP6494  Exp 6/16", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0210-2015", "product_description": "PAPAVERINE HCL/PHENTOLAMINE/ALPROSTADIL, 21.82mg/0.91mg/45mcg, injectable, 1.7 mL glass vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "43 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #:  20140722@16/1.7, discard date: 12/3/2014;  Lot #:  20140728@43/2, discard date: 12/3/2014."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0079-2015", "product_description": "Dihydroergotamine mesylate 1 mg/mL injection solution packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "510 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06162014@34, Exp 9/14/2014; 08142014@39, Exp 11/12/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0222-2015", "product_description": "SODIUM CHLORIDE INHALATION, 7%, Solution for inhalation, 3 mL plastic vial, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "180 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140916@23, discard date: 10/31/2014"}]